Walvax Biotechnology Co., Ltd. (SHE:300142)
12.17
+0.11 (0.91%)
Oct 28, 2026, 3:04 PM CST
| Market Cap | 19.46B +7.2% |
| Revenue (ttm) | 2.10B -17.5% |
| Net Income | 188.77M +1,178.9% |
| EPS | 0.12 +1,163.9% |
| Shares Out | 1.60B |
| PE Ratio | 103.71 |
| Forward PE | n/a |
| Dividend | 0.16 (1.27%) |
| Ex-Dividend Date | Jun 24, 2026 |
| Volume | 39,872,808 |
| Open | 12.25 |
| Previous Close | 12.06 |
| Day's Range | 11.91 - 12.34 |
| 52-Week Range | 10.88 - 16.97 |
| Beta | 0.57 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |